“The immense diagnostic and therapeutic potential of miRNA-based solutions have attracted research institutes, big pharmaceutical companies, and governments of various countries to focus on miRNA research,”.
“There are a number of researches in progress that aim to explore the application of miRNA-based therapeutics as an effective treatment for serious diseases.”
Key Market Drivers
- Increased Investment in miRNA-based Research and Drug Development
- Increase in Prevalence of Chronic Diseases
- Advances in Technology
- Increased miRNA Research Funding
Key Market Trends
- Increased M&A
- Growth of Bioinformatics Software and Services Sector
- Increased Strategic Collaborations and Licensing Activities
Key Market Vendors
- Affymetrix Inc.
- Agilent Technologies Inc.
- Exiqon A/S
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
To define the market circumstances in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
Complete report with TOC available @ Increase in Research Fundings Generating Growth Prospects in the Global miRNA Market.